Manganese-52 positron emission tomography tracer characterization and initial results in phantoms and in vivo

被引:46
|
作者
Topping, Geoffrey J. [1 ]
Schaffer, Paul [2 ]
Hoehr, Cornelia [2 ]
Ruth, Thomas J. [2 ]
Sossi, Vesna [1 ]
机构
[1] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 2B5, Canada
[2] TRIUMF, Nucl Med, Vancouver, BC V6T 2A3, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
Manganese-52; PET; MANGANESE-ENHANCED MRI; BRAIN; ACTIVATION; SIMULATION; EMITTERS; CHROMIUM; SCANNER;
D O I
10.1118/1.4793756
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: Manganese(II) is employed as a contrast agent with magnetic resonance imaging (MRI) for study of neuronal activation in rats and mice. However, at the concentrations required for MRI, Mn may induce pharmacological or toxic effects. Positron emission tomography (PET) imaging of (MnCl2)-Mn-52 at tracer doses has the potential to allow similar Mn studies as manganese-enhanced MRI while providing quantitative results and avoiding toxic effects. In this work, (MnCl2)-Mn-52 is produced and characterized as a PET tracer in phantoms and in rats. Methods: (MnCl2)-Mn-52 was produced by proton irradiation of natural Cr foil and separated by column chromatography. Images were acquired on a Siemens Focus 120 small animal PET scanner. Phantom images were acquired to assess uniformity, resolution, cascade background correction, and count rate linearity. Images of rats were also acquired after systemic and intracerebroventricular (ICV) administration of (MnCl2)-Mn-52 to investigate Mn(II) distribution in vivo. Results: Irradiation yield was 74.6 +/- 8.5 kBq/mu A min Mn-52 at end of bombardment with initial specific activity of at least 3.5 MBq/nmol. Mn-52 PET images show similar uniformity and resolution to F-18. F-18 based detector efficiency normalization is adequate for Mn-52 imaging. Subtraction of a rescaled random events distribution from sinogram data is effective for cascade correction of Mn-52 PET data. After systemic injection, Mn-52 appears in structures throughout the body of rats, including bones, liver, intestines, and the pituitary gland, but does not appear detectably throughout the brain. After ICY injection, Mn-52 remains in the brain and spinal cord. Conclusions: Mn-52 is a promising tracer for small animal PET imaging, yielding image quality comparable to F-18. Potential applications include studies similar to Mn-enhanced neuronal MRI, and in other organ systems including bones, spinal cord, and the digestive tract. (C) 2013 American Association of Physicists in Medicine. [http://dx.doi.org/10.1118/1.4793756]
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Positron emission tomography in the initial staging of esophageal cancer
    Wren, SM
    Stijns, P
    Srinivas, S
    ARCHIVES OF SURGERY, 2002, 137 (09) : 1001 - 1006
  • [32] Evaluation of [18F]pitavastatin as a positron emission tomography tracer for in vivo organic transporter polypeptide function
    Yagi, Yusuke
    Kimura, Hiroyuki
    Okuda, Haruka
    Ono, Masahiro
    Nakamoto, Yuji
    Togashi, Kaori
    Saji, Hideo
    NUCLEAR MEDICINE AND BIOLOGY, 2019, 74-75 : 25 - 31
  • [33] Development of an a-synuclein positron emission tomography tracer for imaging synucleinopathies
    Xiang, Jie
    Tao, Youqi
    Xia, Yiyuan
    Luo, Shilin
    Zhao, Qinyue
    Li, Bowei
    Zhang, Xiaoqian
    Sun, Yunpeng
    Xia, Wencheng
    Zhang, Mingming
    Kang, Seong Su
    Ahn, Eun-Hee
    Liu, Xia
    Xie, Fang
    Guan, Yihui
    Yang, Jenny J.
    Bu, Lihong
    Wu, Shengxi
    Wang, Xiaochuan
    Cao, Xuebing
    Liu, Cong
    Zhang, Zhentao
    Li, Dan
    Ye, Keqiang
    CELL, 2023, 186 (16) : 3350 - +
  • [34] First-in-class positron emission tomography tracer for the glucagon receptor
    Irina Velikyan
    Torsten Haack
    Martin Bossart
    Andreas Evers
    Iina Laitinen
    Philip Larsen
    Oliver Plettenburg
    Lars Johansson
    Stefan Pierrou
    Michael Wagner
    Olof Eriksson
    EJNMMI Research, 9
  • [35] A DUAL TRACER TECHNIQUE FOR POSITRON EMISSION COMPUTED-TOMOGRAPHY (PCT)
    HUANG, SC
    CARSON, RE
    PHELPS, ME
    HOFFMAN, EJ
    KUHL, DE
    JOURNAL OF NUCLEAR MEDICINE, 1981, 22 (06) : P65 - P66
  • [36] First-in-class positron emission tomography tracer for the glucagon receptor
    Velikyan, Irina
    Haack, Torsten
    Bossart, Martin
    Evers, Andreas
    Laitinen, Iina
    Larsen, Philip
    Plettenburg, Oliver
    Johansson, Lars
    Pierrou, Stefan
    Wagner, Michael
    Eriksson, Olof
    EJNMMI RESEARCH, 2019, 9 (1)
  • [37] Key Technologies and Advances of Dual-Tracer Positron Emission Tomography
    Xu Jinmin
    Liu Huafeng
    ACTA OPTICA SINICA, 2022, 42 (17)
  • [38] REQUISITES TO MODELING OF TRACER KINETICS IN THE HEART USING POSITRON EMISSION TOMOGRAPHY
    BOL, A
    MICHEL, C
    MELIN, J
    WIJNS, W
    POSITRON EMISSION TOMOGRAPHY IN CLINICAL RESEARCH AND CLINICAL DIAGNOSIS: TRACER MODELLING AND RADIORECEPTORS, 1989, 15 : 249 - 262
  • [39] Metabolizer in vivo of fullerenes and metallofullerenes by positron emission tomography
    Li, Juan
    Yang, Wenjiang
    Cui, Rongli
    Wang, Dongliang
    Chang, Yanan
    Gu, Weihong
    Yin, Wenyan
    Bai, Xue
    Chen, Kui
    Xia, Lin
    Geng, Huan
    Xing, Gengmei
    NANOTECHNOLOGY, 2016, 27 (15)
  • [40] Imaging bone microdamage in vivo with positron emission tomography
    Li, JL
    Miller, MA
    Hutchins, GD
    Burr, DB
    BONE, 2005, 37 (06) : 819 - 824